Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model

Immune modulators such as anti-thymoglobulin (ATG) are under clinical evaluation for the treatment of type 1 diabetes (T1D). Although such agents have cured T1D in the non-obese diabetic (NOD) model, their clinical efficacy has been much lower. In order to improve the odds of successful translation...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental immunology Vol. 163; no. 3; pp. 375 - 380
Main Authors: Bresson, D, von Herrath, M.G
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01.03.2011
Blackwell
Oxford University Press
Blackwell Science Inc
Subjects:
Rat
ISSN:0009-9104, 1365-2249, 1365-2249
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first